| Literature DB >> 32055542 |
Hyungsub Kim1, Sungpil Han1, Yong-Soon Cho1, Seok-Kyu Yoon1, Kyun-Seop Bae1.
Abstract
Noncompartmental analysis (NCA) is a primary analytical approach for pharmacokinetic studies, and its parameters act as decision criteria in bioequivalent studies. Currently, NCA is usually carried out by commercial softwares such as WinNonlin®. In this article, we introduce our newly-developed two R packages, NonCompart (NonCompartmental analysis for pharmacokinetic data) and ncar (NonCompartmental Analysis for pharmacokinetic Report), which can perform NCA and produce complete NCA reports in both pdf and rtf formats. These packages are compatible with CDISC (Clinical Data Interchange Standards Consortium) standard as well. We demonstrate how the results of WinNonlin® are reproduced and how NCA reports can be obtained. With these R packages, we aimed to help researchers carry out NCA and utilize the output for early stages of drug development process. These R packages are freely available for download from the CRAN repository.Entities:
Keywords: NonCompart; R; ncar; noncompartmental analysis (NCA)
Year: 2018 PMID: 32055542 PMCID: PMC6989226 DOI: 10.12793/tcp.2018.26.1.10
Source DB: PubMed Journal: Transl Clin Pharmacol ISSN: 2289-0882
Description of PK parameters of WinNonlin® and the R packages
| Parameter | WinNonlin® | Description |
|---|---|---|
| b0 | b0 | Intercept |
| CMAX | Cmax | Max Concentration (Conc) |
| CMAXD | Cmax_D | Max Conc Norm by Dose |
| TMAX | Tmax_D | Time of Cmax |
| TLAG | Tlag | Time Until First Nonzero Conc |
| CLST | Clast | Last Nonzero Conc |
| CLSTP | Clast_pred | Last Nonzero Conc Pred |
| TLST | Tlast | Time of Last Nonzero Conc |
| LAMZHL | HL_Lambda_z | Half-Life Lambda z |
| LAMZ | Lambda_z | Lambda z |
| LAMZLL | Lambda_z lower | Lambda z Lower Limit |
| LAMZUL | Lambda_z upper | Lambda z Upper Limit |
| LAMZNPT | No_points_Lambda_z | Number of Points for Lambda z |
| CORRXY | Corr_XY | Correlation Between Time X and Log Conc Y |
| R2 | Rsq | R Squared |
| R2ADJ | Rsq_adjusted | R Squared Adjusted |
| AUCLST | AUClast | AUC to Last Nonzero Conc |
| AUCALL | AUCall | AUC All |
| AUCIFO | AUCINF_obs | AUC Infinity Obs |
| AUCIFOD | AUCINF_D_obs | AUC Infinity Obs Norm by Dose |
| AUCIFP | AUCINF_Pred | AUC Infinity Pred |
| AUCIFPD | AUCINF_D_pred | AUC Infinity Pred Norm by Dose |
| AUCPEO | AUC_Extrap_obs | AUC %Extrapolation Obs |
| AUCPEP | AUC_Extrap_pred | AUC %Extrapolation Pred |
| AUMCLST | AUMClast | AUMC to Last Nonzero Conc |
| AUMCIFO | AUMCINF_obs | AUMC Infinity Obs |
| AUMCIFP | AUMCINF_pred | AUMC Infinity Pred |
| AUMCPEO | AUMC_Extrap_obs | AUMC %Extrapolation Obs |
| AUMCPEP | AUMC_Extrap_pred | AUMC % Extrapolation Pred |
| VZFO | Vz_F_obs | Vz Obs by F |
| VZFP | Vz_F_p | Vz Pred by F |
| CLFO | Cl_F_obs | Total CL Obs by F |
| CLFP | Cl_F_pred | Total CL Pred by F |
| MRTEVLST | MRTlast | MRT Extravasc to Last Nonzero Conc |
| MRTEVIFO | MRTINF_obs | MRT Extravasc Infinity Obs |
| MRTEVIFP | MRTINF_pred | MRT Extravasc Infinity Pred |
Part of Theoph dataset with information on key (subject), time, and concentration
| Subject | Weight (kg) | Dose (mg) | Time (h) | Concentration (mg/ml) |
|---|---|---|---|---|
| 8 | 70.5 | 4.53 | 0 | 0.00 |
| 8 | 70.5 | 4.53 | 0.25 | 3.05 |
| 8 | 70.5 | 4.53 | 0.52 | 3.05 |
| 8 | 70.5 | 4.53 | 0.98 | 7.31 |
| 8 | 70.5 | 4.53 | 2.02 | 7.56 |
| 8 | 70.5 | 4.53 | 3.53 | 6.59 |
| 8 | 70.5 | 4.53 | 5.05 | 5.88 |
| 8 | 70.5 | 4.53 | 7.15 | 4.73 |
| 8 | 70.5 | 4.53 | 9.05 | 4.57 |
| 8 | 70.5 | 4.53 | 12.10 | 3.00 |
| 8 | 70.5 | 4.53 | 24.12 | 1.25 |
Figure 1Example of NonCompart package functions. Example by tblNCA.
Figure 2Examples of ncar package functions. (A) Example of a NCA report in pdf format by pdfNCA, (B) Individual concentration-time plots (left: linear scale, right: log-linear scale).
Comparison of NCA results generated from WinNonlin® and ncar package
| Parameter | WinNonlin® | ncar |
|---|---|---|
| CMAX | 7.56 mg/L | 7.5600 mg/L |
| CMAXD | 0.023625 mg/L/mg | 0.0236 mg/L/mg |
| TMAX | 2.02 h | 2.0200 h |
| TLAG | 0 h | 0.0000 h |
| CLST | 1.25 mg/L | 1.2500 mg/L |
| TLST | 24.12 h | 24.1200 h |
| LAMZHL | 8.510037883 h | 8.5100 h |
| LAMZ | 0.08145054 /h | 0.0815 /h |
| LAMZLL | 3.53 h | 3.5300 h |
| LAMZUL | 24.12 h | 24.1200 h |
| LAMZNPT | 6 | 6 |
| CORRXY | −0.995496053 | −0.9955 |
| R2 | 0.991012391 | 0.991 |
| R2ADJ | 0.988765489 | 0.9888 |
| AUCLST | 88.55995 h*mg/L | 88.5600 h*mg/L |
| AUCALL | 88.55995 h*mg/L | 88.5600 h*mg/L |
| AUCIFO | 103.906687 h*mg/L | 103.9067 h*mg/L |
| AUCIFOD | 0.324708 h*mg/L/mg | 0.3247 h*mg/L/mg |
| AUCIFP | 103.643051 h*mg/L | 103.6431 h*mg/L |
| AUCIFP | 0.323884 h*mg/L/mg | 0.3239 h*mg/L/mg |
| AUCPEO | 14.77% | 14.77% |
| AUCPEP | 14.55% | 14.55% |
| AUMCLST | 739.534598 h2*mg/L | 739.5346 h2*mg/L |
| AUMCIFO | 1298.115755 h2*mg/L | 1298.1158 h2*mg/L |
| AUMCIFP | 1288.520116 h2*mg/L | 1288.5201 h2*mg/L |
| AUMCPEO | 43.03% | 43.03% |
| AUMCPEP | 42.61% | 42.61% |
| VZFO | 37.81050811 L | 37.8105 L |
| VZFP | 37.90668616 L | 37.9067 L |
| CLFO | 3.079686301 L/h | 3.0797 L/h |
| CLFP | 3.087520055 L/h | 3.0875 L/h |
| MRTEVLST | 8.35066639 h | 8.3507 h |
| MRTEVIFO | 12.49309159 h | 12.4931 h |
| MRTEVIFP | 12.43228656 h | 12.4323 h |